Skip to main content

Table 1 General information

From: The clinical applicability of percutaneous splenic vein stent implantation for pancreatic portal hypertension

 

Stent group

Splenectomy group

Conservative group

Number of cases

9

12

12

Male:female ratio

8:1

10:2

11:1

Average age

46.22 ± 9.42

49.58 ± 10.80

38.08 ± 7.40

Clinical manifestations

   

Abdominal pain

3

9

11

Gastrointestinal bleeding

6

4

0

Preoperative laboratory indicators

   

WBC < 3 × 109/L

5

3

1

Hb < 90 g/L

4

3

0

PLT < 100 × 109/L

7

3

3

Preoperative portal CTA

   

Splenic vein occlusion

4

4

3

Splenic vein stenosis

5

8

9

Preoperative EUS

   

Gastric varicose veins

9

12

12

  1. WBC, white blood cell count; Hb, hemoglobin; PLT, platelet count; CTA, computed tomography angiography; EUS, endoscopic ultrasound